Rosuvastatin Tablet, Film Coated
Product Images NDC 71610-796

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Rosuvastatin (NDC 71610-796). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label (71610 0796 30)

Label (71610 0796 30)
Label for Rosuvastatin USP 20 mg film-coated tablets, bottle containing 30 tablets. Manufactured by GSMs, Inc. with repackager Aphena Pharma Solutions - Tennessee, LLC in Cookeville, TN. The label includes storage instructions, barcode, lot number, and expiration date fields.*
FDA Label Image

Aphena (Aphena)

Aphena (Aphena)
FDA Label Image

Figure-01 (Figure 1)

Figure-01 (Figure 1)
A Kaplan-Meier curve chart showing cumulative incidence percentage over five years, comparing Rosuvastatin (Rosuva) and placebo groups. The graph includes hazard ratio (HR 0.56), confidence interval, p-value, and numbers at risk for both groups at multiple time points.*
FDA Label Image

Figure-02 (Figure 2)

Figure-02 (Figure 2)
A data table presenting clinical event rates comparing Rosuvastatin 20 mg and placebo 20 mg groups. It shows number of events and event rates per 1000 patient-years for endpoints including primary endpoint, cardiovascular death, nonfatal stroke, nonfatal myocardial infarction, hospitalized unstable angina, and arterial revascularization. Hazard ratios with 95% confidence intervals and P values are provided alongside a graphical hazard ratio plot.*
FDA Label Image

Figure-02 (Figure 3)

Figure-02 (Figure 3)
A box plot chart comparing percent change from baseline in LDL-C levels for four statins: Rosuvastatin, Atorvastatin, Simvastatin, and Pravastatin. The x-axis shows doses in mg for each drug, while the y-axis represents the percent change from 0 to -75. Box plots illustrate LDL-C reduction variability at each dose level.*
FDA Label Image

Structural Formula (Rosuvastatin Str)

Structural Formula (Rosuvastatin Str)
Chemical structure diagram of rosuvastatin calcium, showing the molecular arrangement including aromatic rings, hydroxyl groups, and calcium ion associations.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.